RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,037 | -32.6% | 25,807 | +0.7% | 0.00% | 0.0% |
| Q2 2023 | $321,875 | -22.5% | 25,627 | +1.6% | 0.00% | 0.0% |
| Q1 2023 | $415,324 | +10.2% | 25,217 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $376,742 | -48.0% | 25,217 | -22.2% | 0.00% | -50.0% |
| Q3 2022 | $725,000 | +33.5% | 32,417 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $543,000 | +6.3% | 32,417 | +89.8% | 0.00% | 0.0% |
| Q1 2022 | $511,000 | -2.5% | 17,077 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $524,000 | +15.2% | 17,077 | +18.4% | 0.00% | 0.0% |
| Q3 2021 | $455,000 | -12.0% | 14,426 | +2.1% | 0.00% | 0.0% |
| Q2 2021 | $517,000 | +53.9% | 14,126 | +45.3% | 0.00% | 0.0% |
| Q1 2021 | $336,000 | +15.9% | 9,720 | +39.5% | 0.00% | 0.0% |
| Q4 2020 | $290,000 | – | 6,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |